Click here to link to original post
Health Advisories
Health Canada is informing Canadians and health care professionals that it is conducting a safety review of Xeljanz and Xeljanz XR (tofacitinib) after a clinical trial identified an increased risk of serious heart-related issues and cancer in trial participants.
Health Canada is advising Canadians not to use face masks that contain graphene because there is a potential that they could inhale graphene particles, which may pose health risks.
Certain lots of hand sanitizers are being recalled from the market because they do not meet Health Canada requirements. Reasons for recall include: